John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
First Trust Natural Gas ETF
FCG
$677M
| $2.69M | 0.01% |
97,900
+15,800
| +19% | +$387K |
|
1252
American Vanguard Corp
AVD
$64M
| $2.68M | 0.01% |
207,275
+43,268
| +26% | +$475K |
|
1253
Nkarta
NKTX
$186M
| $2.68M | 0.01% |
248,147
+108,202
| +77% | +$1.13M |
|
1254
Wabash National
WNC
$491M
| $2.68M | 0.01% |
89,532
-157,881
| -64% | -$4.16M |
|
1255
Annexon
ANNX
$959M
| $2.68M | 0.01% |
373,448
+346,865
| +1,305% | +$1.8M |
|
1256
GeoPark
GPRK
$639M
| $2.67M | 0.01% |
278,620
-139,919
| -33% | -$1.24M |
|
|
NXDR
1257
Nextdoor Holdings
NXDR
$917M
| $2.67M | 0.01% |
1,186,375
-64,216
| -5% | -$120K |
|
|
SAVE
1258
DELISTED
Spirit Airlines, Inc.
SAVE
| $2.67M | 0.01% |
+551,499
| New | +$4.08M |
|
1259
Simmons First National
SFNC
$3.32B
| $2.67M | 0.01% |
137,154
+33,136
| +32% | +$628K |
|
|
ZYXI
1260
DELISTED
Zynex
ZYXI
| $2.67M | 0.01% |
215,568
+32,449
| +18% | +$389K |
|
1261
TTM Technologies
TTMI
$11.3B
| $2.67M | 0.01% |
170,320
+136,851
| +409% | +$2.03M |
|
1262
Avnet
AVT
$7.08B
| $2.66M | 0.01% |
53,631
-97,111
| -64% | -$4.55M |
|
1263
Titan Machinery
TITN
$444M
| $2.65M | 0.01% |
107,006
+65,475
| +158% | +$1.71M |
|
1264
Minerals Technologies
MTX
$2.24B
| $2.65M | 0.01% |
35,196
+16,276
| +86% | +$1.14M |
|
|
ALCY
1265
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
| $2.65M | 0.01% |
250,000
| – | – |
|
|
NOA
1266
North American Construction
NOA
$361M
| $2.64M | 0.01% |
118,689
-96,261
| -45% | -$2.24M |
|
1267
Krispy Kreme
DNUT
$626M
| $2.64M | 0.01% |
+173,177
| New | +$2.31M |
|
1268
Vital Farms
VITL
$476M
| $2.63M | 0.01% |
112,960
+81,211
| +256% | +$1.42M |
|
1269
PUT
PG&E
PCG
$39.9B
| $2.62M | 0.01% |
156,400
+120,000
| +330% | +$2.01M |
|
|
VMEO
1270
DELISTED
Vimeo
VMEO
| $2.61M | 0.01% |
637,537
-1,083,924
| -63% | -$4.62M |
|
1271
Movado Group
MOV
$772M
| $2.6M | 0.01% |
93,125
+53,820
| +137% | +$1.51M |
|
1272
DT Midstream
DTM
$12.8B
| $2.6M | 0.01% |
+42,549
| New | +$2.37M |
|
|
XHR
1273
Xenia Hotels & Resorts
XHR
$1.81B
| $2.6M | 0.01% |
173,144
+117,745
| +213% | +$1.64M |
|
1274
Amplify Junior Silver Miners ETF
SILJ
$4.23B
| $2.6M | 0.01% |
261,700
-84,600
| -24% | -$756K |
|
1275
Essex Property Trust
ESS
$18.9B
| $2.59M | 0.01% |
10,594
+2,894
| +38% | +$689K |
|
Similar funds
John Overdeck's Q1 2024 Portfolio in Review
As of Q1 2024, John Overdeck held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
John Overdeck withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, John Overdeck opened a new position in Pfizer worth $234M.
- John Overdeck's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- John Overdeck added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- John Overdeck's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- John Overdeck fully exited Rivian in Q1 2024, selling an estimated $158M.
- John Overdeck's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- John Overdeck opened 408 new positions and closed 532 in Q1 2024.
- John Overdeck's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.